SEC Form 4 · accession 0001246360-17-000413
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig W Moore
Director
Period of report
Feb 1, 2017
Accepted (ET)
Feb 2, 2017 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2017 | M | 15,272 | $14.99 | A | 104,511 | D | |
| Common Stock | Feb 1, 2017 | F | 8,568 | $26.72 | D | 95,943 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.99 | Feb 1, 2017 | M | 15,272 | D | May 24, 2012 | May 23, 2017 | Common Stock | 15,272 | 0 | D |